DR. SELLS VEJ 16 ApS: Financial statements 2023
CVR: 26671132
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
DR. SELLS VEJ 16 ApS (CVR 26671132) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 7,209 and a net result of DKK 25,965 compared with DKK -57,317 the year before. That is a decrease of 32.3% compared with the year before. Equity in the 2023 report amounted to DKK 645,785. The solvency ratio was 95.8%.
- Gross Profit
- DKK 7,209
- Profit/Loss
- DKK 25,965
- Equity
- DKK 645,785
- Total Assets
- DKK 674,339
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 7K | 26K | 646K | - |
| 2022 | - | 11K | -57K | 620K | - |
| 2021 | - | 70K | 62K | 977K | - |
| 2020 | - | 70K | 60K | 915K | - |
| 2019 | - | 70K | 60K | 855K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
DR. SELLS VEJ 16 ApS has published its annual report for 2022. Gross profit came to DKK 10,648, and the net result was DKK -57,317.
About DR. SELLS VEJ 16 ApS
DR. SELLS VEJ 16 ApS was a Danish company of the type Anpartsselskab based in Slagelse, founded in 2002. The company has been dissolved on 29 May 2024. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. In 2023, the company reported a gross profit of DKK 7,209 and a net result of DKK 25,965 compared with DKK -57,317 the year before. Equity in the 2023 report amounted to DKK 645,785.
